Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Health Care Utilization and Mortality in People Living with Migraine and Comorbid Depression: A Retrospective Cohort Study
Headache
P3 - Poster Session 3 (5:30 PM-6:30 PM)
12-006

In people suffering from migraine headaches, co-existent mental health conditions like depression have a significant effect on quality of life, albeit, data on unplanned resource utilization is limited.

Report how depression affects mortality and unplanned healthcare utilization of patients with migraine by utilizing Patient-Reported Outcomes Measurement Information System (PROMIS) scores collected in routine practice at neurology clinics within an academic health system.

A retrospective, single center cohort analysis was performed of PROMIS depression measures from 2018 through 2023. We evaluated the effect of these measures on unplanned resource utilization as measured by Mortality – all cause, Hospitalization - all cause, ED Treatment and Telease - all cause, and Urgent Care - all cause, at 7, 30, and 90-days from index clinic visit. Univariate analysis was utilized to evaluate differences between groups.

The cohort consisted of 21,177 unique patients suffering from migraine headaches, totaling 39,590 encounters. Within our cohort, the incidence of depression was 8.9%, median age was 43.8 yrs, with 83.5% being female. Patients with abnormal PROMIS Depression scores (>60) were more likely to experience adverse outcomes. At 30 days post the index visit, their likelihood of mortality was significantly higher (10.039, 95% CI: 1.044-96.538), as was the case at 90 days (4.688, 95% CI: 1.487-14.77). Additionally, they were more prone to hospitalization for all causes at both 30 days (1.327, 95% CI: 1.02-1.72) and 90 days (1.52, 95% CI: 1.29-1.79). Furthermore, they exhibited increased utilization of emergency department services at 7 days (1.55, 95% CI: 1.169-2.059), 30 days (1.32, 95% CI: 1.02-1.72), and 90 days (1.724, 95% CI: 1.54-1.921).

People living with migraine headaches with comorbid depression were more likely to experience all-cause mortality and unplanned hospitalization at 30 and 90 days. Adequate treatment of depression in people with migraine may be critical in improving these outcomes.

Authors/Disclosures
Thomas Williams, MD (UPMC)
PRESENTER
Dr. Williams has nothing to disclose.
Conor Kelly, MD (UPMC) Dr. Kelly has nothing to disclose.
Robert G. Kaniecki, MD (The University of Pittsburgh Headache Center) Dr. Kaniecki has nothing to disclose.
Jason Raad (University of Pittsburgh) No disclosure on file
Janel Hanmer (University of Pittsburgh Medical Center) No disclosure on file
Manisha Jhamb (University of Pittsburgh) No disclosure on file
Parthasarathy Thirumala, MD, FAAN (University of Pittsburgh Medical Center) The institution of Dr. Thirumala has received research support from University of Pittsburgh.